Plasma lipidomics reveals potential lipid markers of major depressive disorder
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) is a grave debilitating mental disease with a high incidence and severely impairs quality of life. Therefore, its physiopathological basis study and diagnostic biomarker discovery are extremely valuable. In this study, a non-targeted lipidomics strategy using ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS) was performed to reveal differential lipids between MDD (n = 60) and healthy controls (HCs, n = 60). Validation of changed lipid species was performed in an independent batch including 75 MDD and 52 HC using the same lipidomic method. Pronouncedly changed lipid species in MDD were discovered, which mainly were lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), 1-O-alkyl-2-acyl-PE (PE O), 1-O-alkyl-2-acyl-PC (PC O), sphingomyelin (SM), diacylglycerol (DG), and triacylglycerol (TG). Among these lipid species, LPC, LPE, PC, PE, PI, TG, etc. remarkably increased in MDD and showed pronounced positive relationships with depression severity, while 1-O-alkyl-2-acyl-PE and SM with odd summed carbon number significantly decreased in MDD and demonstrated negative relationships with depression severity. A combinational lipid panel including LPE 20:4, PC 34:1, PI 40:4, SM 39:1, 2, and TG 44:2 was defined as potential diagnostic biomarker with a good sensitivity and specificity for distinguishi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These clinical data suggest that sex differences in MDD may result from differences in OS and lipid metabolism, but further research is required to make this connection.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [458]
In the citing paper
“as 1-Oalkyl-2-acyl-PEs levels are decreased in MDD, showing a negative correlation with the extent of depression, lysophospholipid (LPC) and phospholipid (PC) levels are increased in MDD, exhibiting a substantial positive correlation with depression severity. 458”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [458]
In the citing paper
“Several studies have indicated an association between the lipid concentrations of octadecyl-phosphatidylethanolamine (PE-O) [58], SM, and PC-O [63] and symptom severity according to the specific scales.”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [58]
In the citing paper
“Thus, lipid related metabolites have also been suggested to be involved in the pathophysiology of MDD (Liu et al., 2016;Parekh et al., 2017;Shelton and Miller, 2010).”
From Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study (2018) · cites this paper as Liu et al., 2016
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“MDD, with its high incidence, has affected a wide range of people by giving rise to severe impairments in quality of life [1, 2].”
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Clinical diagnosis of depression in primary care: a meta-analysis
Mitchell, A. J., Vaze, A., & Rao, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60879-5 · Cited by 1,251 · cited 1×
“What is more, at present, MDD diagnosis solely depends on symptom and clinical manifestation, and current diagnostic methods lead to a high misdiagnosis rate [6].”
Hypertriglyceridemia as a cardiovascular risk factor
Austin, M. A., Hokanson, J. E., & Edwards, K. L. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00031-9 · Cited by 1,066
Slusarski, D. C., Corces, V. G., & Moon, R. T. (1997) · Nature · doi:10.1038/37138 · Cited by 680 · cited 1×
“PI, a kind of phospholipid, worked as downstream effectors in G-protein linked signaling system (GPLS) [34].”
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
Depression as an Antecedent to Heart Disease Among Women and Men in the NHANES I Study
Ferketich, A. K., Schwartzbaum, J. A., Frid, D. J., & Moeschberger, M. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1261 · Cited by 490
Uher, R., Payne, J. L., Pavlova, B., & Perlis, R. H. (2014) · Depression and Anxiety · doi:10.1002/da.22217 · Cited by 456 · cited 1×
“Mental Disorders criteria for MDD (DSM-IV) were adopted to diagnose MDD patients in our study [23].”
Fuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Cited by
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“458 Similarly, a study found that men and women had different lipid concentrations.”
BackgroundBiomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Zheng, P., Wu, J., Zhang, H., Perry, S. W., Yin, B., Tan, X., Chai, T., Liang, W., Huang, Y., Li, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0744-2 · Cited by 205
Self-citationPeripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
“The lipid profile is disturbed in depression, but the exact character of the changes has not been fully elucidated [314].”
BackgroundAmin, N., Liu, J., Bonnechère, B., MahmoudianDehkordi, S., Arnold, M., Batra, R., Chiou, Y., Fernandes, M., Ikram, M. A., Kraaij, R., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.0685 · Cited by 168
Tian, T., Mao, Q., Xie, J., Wang, Y., Shao, W., Zhong, Q., & Chen, J. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.10.002 · Cited by 153
Lipids as biomarkers of brain disorders
Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S. K. S., Aziz, N., Razzaq, A., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 103
Fernandes, M., Mutch, D., & Leri, F. (2017) · Nutrients · doi:10.3390/nu9030298 · Cited by 90
Curcumin Alleviates DSS‐Induced Anxiety‐Like Behaviors via the Microbial‐Brain‐Gut Axis
Zhang, F., Zhou, Y., Chen, H., Jiang, H., Zhou, F., Lü, B., & Xu, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6244757 · Cited by 98
Is depression the missing link between inflammatory mediators and cancer?
Polityńska, B., Pokorska, O., Wojtukiewicz, A. M., Sawicka, M., Mysliwiec, M., Honn, K. V., Tucker, S. C., & Wojtukiewicz, M. Z. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108293 · Cited by 89
Tkachev, A., Stekolshchikova, E., Vanyushkina, A., Zhang, H., Morozova, A. Y., Zozulya, S. A., Kurochkin, I., Anikanov, N. A., Egorova, A., Yushina, E., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.4350 · Cited by 82
Self-citationBiomarkers for Depression: Recent Insights, Current Challenges and Future Prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2018) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.16206 · Cited by 78
Chen, D., Zhao, X., Sui, Z., Niu, H., Chen, L., Hu, C., Xuan, Q., Hou, X., Zhang, R., Zhou, L., et al. (2020) · Theranostics · doi:10.7150/thno.41106 · Cited by 78
Self-citationLipidomics in Major Depressive Disorder
Walther, A., Cannistraci, C. V., Simons, K., Durán, C., Gerl, M. J., Wehrli, S., & Kirschbaum, C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00459 · Cited by 77
“The authors reported that several differential lipid species were significantly correlated with depression severity measured by the Hamilton Depression Scale (HAMD) (42).”
MethodSabogal-Guáqueta, A. M., Villamil-Ortiz, J. G., Arias-Londoño, J. D., & Cardona‐Gómez, G. P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00989 · Cited by 74
Kuwano, N., Kato, T. A., Setoyama, D., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Kishimoto, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.01.014 · Cited by 69
“Therefore, lipid species have been suggested to enhance existing knowledge of brain diseases including MDD (Fonteh et al., 2006; Liu et al., 2016; Liu et al., 2015b).”
InfluentialLipidomics: Prospects from a technological perspective
Triebl, A., Hartler, J., Trötzmüller, M., & Köfeler, H. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.03.004 · Cited by 64
The metabolome-wide signature of major depressive disorder
Jansen, R., Milaneschi, Y., Schranner, D., Kastenmüller, G., Arnold, M., Han, X., Dunlop, B. W., Rush, A. J., Kaddurah‐Daouk, R., & Penninx, B. W. J. H. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02613-6 · Cited by 62
LIPEA: Lipid Pathway Enrichment Analysis
Acevedo, A., Durán, C., Ciucci, S., Gerl, M., & Cannistraci, C. V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/274969 · Cited by 49
Rathour, D., Shah, S., Khan, S., Singh, P. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114081 · Cited by 61
Biomarkers of Major Depressive Disorder: Knowing is Half the Battle
Malik, S., Singh, R., Arora, G., Dangol, A., & Goyal, S. (2021) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2021.19.1.12 · Cited by 42
Adaptation of Lipid Profiling in Depression Disease and Treatment: A Critical Review
Pinto, B., Conde, T., Domingues, I., & Domingues, M. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042032 · Cited by 51
“This can also be a result of increased oxidative stress observed in individuals with depression [67].”
BackgroundMadrid-Gambín, F., Föcking, M., Sabherwal, S., Heurich, M., English, J. A., O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Lewis, G., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.018 · Cited by 49
Walther, A., Mackens-Kiani, A., Eder, J., Herbig, M., Herold, C., Kirschbaum, C., Guck, J. R., Wittwer, L. D., Beesdo‐Baum, K., & Kräter, M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01911-3 · Cited by 49
Udagawa, J., & Hino, K. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.08.008 · Cited by 49
Liu, Y., Song, X., Liu, X., Pu, J., Gui, S., Xu, S., Tian, L., Zhong, X., Zhao, L., Wang, H., et al. (2021) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13194 · Cited by 48
Self-citationMetabolomics of lung cancer: Analytical platforms and their applications
Noreldeen, H. A. A., Liu, X., & Xu, G. (2019) · Journal of Separation Science · doi:10.1002/jssc.201900736 · Cited by 49
Self-citationYan, Y., Li, J., Zhang, Y., Wang, H., Qin, X., Zhai, K., & Du, C. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154853 · Cited by 46
Self-citationFilho, A. J. M. C., Braniff, O., Angelova, A., Deng, Y., & Tremblay, M. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110702 · Cited by 44
Miao, G., Deen, J. F., Struzeski, J. B., Chen, M., Zhang, Y., Cole, S. A., Fretts, A. M., Lee, E. T., Howard, B. V., Fiehn, O., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-01948-w · Cited by 43
Ge, Z., Hu, Y., Kan, W., Li, L., Xu, J., Zhang, Y., Zheng, N., Wang, G., & Du, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625087 · Cited by 42
Huang, X., Li, W., You, B., Tang, W., Gan, T., Feng, C., Li, C., & Yang, R. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02895 · Cited by 42
Hisano, K., Kawase, S., Mimura, T., Yoshida, H., Yamada, H., Haniu, H., Tsukahara, T., Kurihara, T., Matsuda, Y., Saito, N., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.11.119 · Cited by 41
Wu, J., Chai, T., Zhang, H., Huang, Y., Perry, S. W., Li, Y., Duan, J., Tan, X., Hu, X., Liu, Y., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01836-x · Cited by 41
Self-citationXie, J., Zhong, Q., Wu, W.-T., & Chen, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03942-w · Cited by 41
Liao, X.-X., Hu, K., Xie, X.-H., Wen, Y.-L., Wang, R., Hu, Z., Zhou, Y.-L., Li, J.-J., Wu, M.-K., Yu, J., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116468 · Cited by 38
Self-citationShao, T. N., Yin, G., Yin, X. L., Wu, J. Q., Du, X., Zhu, H. L., Liu, J. H., Wang, X. Q., Xu, D. W., Tang, W. J., et al. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.03.007 · Cited by 38
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36
Zoicas, I., Mühle, C., Schmidtner, A. K., Gulbins, E., Neumann, I. D., & Kornhuber, J. (2020) · Cells · doi:10.3390/cells9051239 · Cited by 37
Péterfalvi, Á., Németh, N., Herczeg, R., Tényi, T., Miseta, A., Czéh, B., & Simon, M. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01798 · Cited by 34
Fan, Y., Noreldeen, H. A. A., You, L., Liu, X., Pan, X., Hou, Z., Li, Q., Li, X., & Xu, G. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113520 · Cited by 34
Self-citationGong, W., Chen, J., Xu, S., Li, Y., Zhou, Y., & Qin, X. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117217 · Cited by 34
Gong, X., Huang, C., Yang, X., Chen, J., Pu, J., He, Y., & Xie, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.701355 · Cited by 33
Self-citationXu, K., Ren, Y., Zhao, S., Feng, J., Wu, Q., Gong, X., Chen, J., & Xie, P. (2024) · Communications Biology · doi:10.1038/s42003-023-05759-1 · Cited by 32
Self-citationGuo, L., Zhang, T., Li, R., Cui, Z.-Q., Du, J., Yang, J.-B., Xue, F., Chen, Y., Tan, Q.-R., & Peng, Z. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.802710 · Cited by 32
Liu, K., Fang, J., Jing, J., Zhu, S., Xu, X., Xu, Y., Ye, B., Lin, S., & Xu, X. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00574 · Cited by 31
Li, Y., Dang, X., Chen, R., Teng, Z., Wang, J., Li, S., Yue, Y., Mitchell, B. L., Zeng, Y., Yao, Y.-G., et al. (2025) · Nature Human Behaviour · doi:10.1038/s41562-024-02073-6 · Cited by 30
Altered lipidomic profiles in lung and serum of rat after sub-chronic exposure to ozone
Liu, Z., Xu, P., Gong, F., Tan, Y., Han, J., Tian, L., Yan, J., Li, K., Xi, Z., & Liu, X. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150630 · Cited by 30
Self-citationPlasma sphingolipids and depressive symptoms in coronary artery disease
Dinoff, A., Saleem, M., Herrmann, N., Mielke, M. M., OH, P. I., Venkata, S. L. V., Haughey, N. J., & Lanctôt, K. L. (2017) · Brain and Behavior · doi:10.1002/brb3.836 · Cited by 30
Li, Y., Dang, X., Chen, R., Wang, J., Li, S., Mitchell, B. L., Yao, Y.-G., Li, M., Li, T., Zhang, Z., et al. (2023) · doi:10.1101/2023.02.24.23286411 · Cited by 30
Abnormalities of lipid metabolism in the progression and treatment of depression
Luan, X., Wang, X., Shi, Y., Zhang, X., Wang, Y., Zhou, M., Wu, Z., Liu, Z., Li, X., Zhang, L., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1589663 · Cited by 30
Sun, X., Ma, L., Chen, Z., Xiong, Y., Jia, J., Wang, Y., & Ren, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1251955 · Cited by 29
Zoicas, I., Schumacher, F., Kleuser, B., Reichel, M., Gulbins, E., Fejtová, A., Kornhuber, J., & Rhein, C. (2020) · Cells · doi:10.3390/cells9051244 · Cited by 28
Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
Zhang, T., Guo, L., Li, R., Wang, F., Yang, W., Yang, J.-B., Cui, Z.-Q., Zhou, C., Chen, Y., Yu, H., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.927817 · Cited by 27
Self-citationKoenig, A. M., Karabatsiakis, A., Stoll, T., Wilker, S., Hennessy, T., Hill, M. M. C., & Kolassa, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-21763-6 · Cited by 26
Yang, Y., Zhong, Q., Zhang, H., Mo, C., Yao, J., Huang, T., Zhou, T., & Tan, W. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.05.022 · Cited by 26
Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors
Schüle, L., Glasmacher, S., Gertsch, J., Roggan, M. D., Transfeld, J. L., Bîndilă, L., Lutz, B., Kolbe, C., Bilkei‐Gorzó, A., Zimmer, A., et al. (2020) · Glia · doi:10.1002/glia.23903 · Cited by 25
Riya, S., Sultana, S., Daria, S., Proma, M. A., Bhuiyan, M. A., Haque, M. A., & Islam, M. R. (2020) · Cureus · doi:10.7759/cureus.12388 · Cited by 24
mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
Rhein, C., Zoicas, I., Marx, L. M., Zeitler, S., Hepp, T., von Zimmermann, C., Mühle, C., Richter‐Schmidinger, T., Lenz, B., Erim, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115700 · Cited by 24
Association between triglyceride and depression: A systematic review and meta-analysis
Xu, D.-R., Gao, X., Zhao, L., Liu, S., Tang, G., Zhou, C., & Chen, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311625 · Cited by 23
Self-citationA review of new insights into existing major depressive disorder biomarkers
Rimti, F. H., Shahbaz, R., Bhatt, K., & Xiang, A. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18909 · Cited by 23
Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences
Singh, P., Vasundhara, B., Das, N., Sharma, R., Kumar, A., & Datusalia, A. K. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04302-5 · Cited by 21
Portlock, T., Shama, T., Kakon, S. H., Hartjen, B., Pook, C. J., Wilson, B. C., Bhuttor, A., Ho, D., Shennon, I., Engelstad, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55798-3 · Cited by 21
Lipidomic signature of serum from the rats exposed to alcohol for one year
Li, H., Xu, W., Jiang, L., Gu, H., Li, M., Zhang, J., Guo, W., Deng, P., Long, H., Bu, Q., et al. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.05.011 · Cited by 21
Waly, B. E., Buttigieg, E., Karakus, C., Brustlein, S., & Debarbieux, F. C. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00165 · Cited by 20
Homorogan, C., Nitusca, D., Enatescu, V., Schubart, P., Moraru, C., Socaciu, C., & Marian, C. (2021) · Metabolites · doi:10.3390/metabo11070466 · Cited by 19
“Furthermore, Liu et al. (2016) attempted to analyse the relationships of specific metabolites with depression severity in a plasma lipidomic report.”
BackgroundMetabolic Modulators in Depression: Emerging Molecular Mechanisms and Therapeutic Opportunities
Dyndał, K., Pańczyszyn-Trzewik, P., & Sowa-Kućma, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178755 · Cited by 19
Jin, M., Zhang, S., Huang, B., Li, L., Liang, H., Ni, A., Han, L., Liang, P., Liu, J., Shi, H., et al. (2024) · Brain and Behavior · doi:10.1002/brb3.3448 · Cited by 19
Wang, F., Guo, L., Zhang, T., Cui, Z., Wang, J., Zhang, C., Xue, F., Zhou, C., Li, B., Tan, Q., et al. (2022) · Medicina · doi:10.3390/medicina58111509 · Cited by 18
“However, these identified lipid panels were inconsistent with a previous study [63], which may be related to the sex, region, and symptom characteristics of enrolled individuals as well as the analysis method, which need to be further verified by clinical studies with larger samples in the future.”
MethodSelf-citationChen, W., Shao, S., Cai, H., Han, J., Guo, T., Fu, Y., Yu, C., Zhao, M., Bo, T., Yao, Z., et al. (2020) · International Journal of Endocrinology · doi:10.1155/2020/9501826 · Cited by 17
Self-citationChen, G., Zhang, W., Chen, Q., Dong, M.-X., Liu, M., & Liu, G. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111182 · Cited by 16
Screening for depression in the general population through lipid biomarkers
Tkachev, A., Stekolshchikova, E., Golubova, A., Serkina, A., Morozova, A. Y., Zorkina, Y., Riabinina, D., Golubeva, E., Ochneva, A., Savenkova, V., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105455 · Cited by 15
Wang, Y., Chen, H., Wang, J., Chen, S., Liu, J., Chen, X., Li, S., Tang, H., Zhou, J., Ye, Y., et al. (2025) · Depression and Anxiety · doi:10.1155/da/5564796 · Cited by 15
Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkers
Yu, Q., Liu, X., Huang, H., Zheng, X., Pan, X., Fang, J., Meng, L., Zhou, C., Zhang, X., Li, Z., et al. (2019) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284819886425 · Cited by 14
Self-citationSerum Metabolic Profiling of Late-Pregnant Women With Antenatal Depressive Symptoms
Mao, Q., Tian, T., Chen, J., Guo, X., Zhang, X., & Zou, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.679451 · Cited by 13
Zhou, C., Xue, F., Shi, Q., Xue, S., Zhang, T., Ma, X., Yu, L., Liu, C., Wang, H., & Peng, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.812479 · Cited by 13
Self-citationLiu, H., Liu, N., Teng, W., & Chen, J. (2018) · Journal of Chromatography B · doi:10.1016/j.jchromb.2018.07.040 · Cited by 13
Werner, F., Schumacher, F., Mühle, C., Adler, W., Schug, C., Schäflein, E., Morawa, E., Kleuser, B., Kornhuber, J., Erim, Y., et al. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-01985-2 · Cited by 12
Zhou, C., Zhao, X., Ma, X., Ma, H., Li, R., Hu, G., Wang, H., Peng, Z., & Cai, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1114914 · Cited by 12
Self-citationKumar, R., Núñez, N. A., Joshi, N. S., Joseph, B., Verde, A., Seshadri, A., Barboza, A. B. C., Prokop, L. J., Medeiros, G. C., & Singh, B. (2024) · Bipolar Disorders · doi:10.1111/bdi.13412 · Cited by 12
Danyang, L., Yang, J., Jin, W., Zhong, Q., & Zhou, T. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03349-w · Cited by 12
Gurke, R., Etyemez, S., Prvulovic, D., Thomas, D., Fleck, S. C., Reif, A., Geißlinger, G., & Lötsch, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00041 · Cited by 12
Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia
Tkachev, A., Stekolshchikova, E., Anikanov, N., Zozulya, S., Barkhatova, A., Klyushnik, T., & Petrova, D. (2021) · Biomolecules · doi:10.3390/biom11050720 · Cited by 11
Metabolomic profiles in night shift workers: A cross-sectional study on hospital female nurses
Borroni, E., Frigerio, G., Polledri, E., Mercadante, R., Maggioni, C., Fedrizzi, L., Pesatori, A. C., Fustinoni, S., & Carugno, M. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1082074 · Cited by 11
Zoicas, I., Mühle, C., Schumacher, F., Kleuser, B., & Kornhuber, J. (2023) · Cells · doi:10.3390/cells12101355 · Cited by 11
Gary, A. A., Prislovsky, A., Tovar, A., Locatelli, E. V. T., Felix, E. R., Stephenson, D., Chalfant, C. E., Lai, J. M., Kim, C. K., Mandal, N. A., et al. (2023) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14343 · Cited by 11
Ang, S.-H., Ho, R., McIntyre, R. S., Zhang, Z., Chang, S.-K., Teopiz, K. M., & Ho, C. S. H. (2025) · Psychiatry Investigation · doi:10.30773/pi.2024.0152 · Cited by 10
Bisle, E., Haange, S., Rojas, R., Behnke, A., Karabatsiakis, A., Gumpp, A. M., Mack, M., Mavioğlu, R. N., Lutz‐Bonengel, S., Rolle-Kampczyk, U. E., et al. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116569 · Cited by 10
Metabolic lipid alterations in subclinical ketotic dairy cows: A multisample lipidomic approach
He, Y. R., Zhao, H. Y., Li, L., Tan, J., Wang, Y., Zhao, Y., & Jiang, L. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26442 · Cited by 10
Yin, H., Lu, B., Zeng, K., Li, Y., & Ma, J. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05848-3 · Cited by 10
Cen, Q., Cui, Y., Jin, J., Feng, J., Xin, Y., Zhang, Z., Li, J., Wang, J., & Zhang, A. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2576657 · Cited by 9
Self-citationWei, J., Zhang, Z., Du, Y., Yang, X., Zhao, L., Ni, P., Ni, R., Gong, M., & Ma, X. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.108 · Cited by 9
Jaber, M. H., Kahwaji, H., Nasr, S., Baz, R., Kim, Y., & Fakhoury, M. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_18 · Cited by 9
Wei, J., Zhang, Z., Yang, X. L., Zhao, L., Wang, M., Dou, Y., Yan, Y., Ni, R., Gong, M., Dong, Z., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.12.072 · Cited by 9
An Overview of Metabolic Phenotyping and Its Role in Systems Biology
Holmes, E. C., Wilson, I. D., & Lindon, J. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812293-8.00001-3 · Cited by 8
Tang, X., He, Q., Liu, X., & Fu, Q. (2025) · Medicine · doi:10.1097/md.0000000000042337 · Cited by 7
Self-citationImpact of St. John’s wort extract Ze 117 on stress induced changes in the lipidome of PBMC
Bussmann, H., Bremer, S., Häberlein, H., Boonen, G., Drewe, J., Butterweck, V., & Franken, S. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00644-3 · Cited by 7
LC–HRMS Lipidomic Fingerprints in Serbian Cohort of Schizophrenia Patients
Marković, S., Jadranin, M. B., Miladinović, Z. P., Gavrilović, A., Avramović, N., Takić, M. M., Tasić, L., Tešević, V., & Mandić, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910266 · Cited by 6
Wang, Y., Xu, D., Liu, X., Cheng, M., Huang, J., Liu, D., Zhang, X., & Zhang, L. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116572 · Cited by 6
Self-citationSphingolipids in Emotional Well‐Being
Kalinichenko, L. S., Zoicas, I., Muehle, C., Kornhuber, J., & Müller, C. P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70379 · Cited by 6
Metadata
- Authors
- Liu, X., Li, J., Zheng, P., Zhao, X., Zhou, C., Hu, C., Hou, X., Wang, H., Xie, P., & Xu, G.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Corresponding author
- Xie, Peng
- Xu, Guowang
- ORCID
- Venue
- Analytical and Bioanalytical Chemistry
- Published
- 2016-07-25
- Volume
- 408
- Issue
- 23
- Pages
- 6497-6507
- ISSN
- 1618-2642 (ISSN-L)
- 1618-2650
- OpenAlex
- W2496213445
- Cited by
- 148
- References
- 42
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 25 · 2023: 20 · 2022: 16 · 2021: 12 · 2020: 13 · 2019: 9 · 2018: 10 · 2017: 5
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Analytical and Bioanalytical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Dalian Institute of Chemical Physics, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (81401140)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, plasma lipidomics, diagnostic biomarkers, lipid species, lysophosphatidylcholine, lysophosphatidylethanolamine, phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, sphingomyelin, diacylglycerol, triglycerides, depression severity, lipid metabolism disorders
- MeSH terms
- Adult, Chromatography, High Pressure Liquid, Major Depressive Disorder, Female, Humans, Lipids, Male, Middle Aged, Quality of Life, Sensitivity and Specificity, Mass Spectrometry, Biomarkers, Lipid Metabolism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.